VIIBRYD 40 mg/1 (Vilazodone Hydrochloride TABLET) 40 mg/1

VIIBRYD 40 mg tablets contain vilazodone hydrochloride, an antidepressant used to manage major depressive disorder. This medication works by balancing serotonin levels in the brain, offering relief from depressive symptoms.

Strength

40 mg/1

Pack Size

30 TABLET in 1 BOTTLE (0456-1140-30)

Manufacturer / TM Owner

Allergan, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VIIBRYD 40 mg tablets are primarily used to treat major depressive disorder. This medication is designed to help manage symptoms such as persistent sadness, loss of interest, and changes in appetite or sleep. It is often prescribed when other treatments have not been effective. What is VIIBRYD used for? It is used for the management of depressive episodes in adults.

Side Effects

Common effects of VIIBRYD 40 mg tablets may include nausea, diarrhea, and dizziness. Some users may also experience dry mouth or changes in appetite. These effects are generally mild and may improve as the body adjusts to the medication.

Precautions & Warnings

VIIBRYD 40 mg tablets should be handled with care. It is important to follow the prescribed dosage and avoid sudden discontinuation. Patients with a history of seizures, bipolar disorder, or liver problems should consult their healthcare provider before use. Keep out of reach of children.

Avoid Interactions

VIIBRYD 40 mg tablets may interact with other medications, including MAO inhibitors, SSRIs, and certain pain relievers. Alcohol and other CNS depressants should be avoided as they can enhance the sedative effects. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

VIIBRYD is used to treat major depressive disorder in adults.

VIIBRYD should be taken orally, typically once daily, with or without food.

Common side effects include nausea, diarrhea, dizziness, and dry mouth.

VIIBRYD may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

VIIBRYD may not be suitable for everyone, especially those with certain medical conditions or a history of seizures.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.